Compare MPLX LP (MPLX) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MPLX LP vs Summit Therapeutics Inc — how do they compare? MPLX LP trades at $56.75 (market cap $57.97B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: MPLX LP is far larger — about 5.5× Summit Therapeutics Inc's market cap, and MPLX LP pays a 7.54% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| MPLX | SMMT | |
|---|---|---|
Market Cap | $57.97B | $10.48B |
Sector | Technology | Health |
52-Week High | $59.17 | $29.32 |
52-Week Low | $47.80 | $13.05 |
Enterprise Value | $82.60B | $9.90B |
Dividend Yield | 7.54% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MPLX LP
MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.
Read more on MPLX →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
